Show
Sort by
-
- Journal Article
- A1
- open access
Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation : a nationwide cohort study
-
- Journal Article
- A1
- open access
The impact of polypharmacy on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
-
Pharmacodynamic drug-drug interactions and bleeding outcomes in patients with atrial fibrillation using non-vitamin K antagonist oral anticoagulants : a nationwide cohort study
-
- Journal Article
- A1
- open access
Potentially inappropriate prescribing in multimorbid and polymedicated older adults with AF : a systematic review and meta-analysis
-
Rational oral anticoagulant use in patients with atrial fibrillation
(2023) -
- Journal Article
- A1
- open access
Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation : a nationwide cohort study
-
- Journal Article
- A1
- open access
Non-vitamin K antagonist oral anticoagulants (NOACs) versus warfarin in patients with atrial fibrillation using P-gp and/or CYP450-interacting drugs : a systematic review and meta-analysis
-
- Journal Article
- A2
- open access
Clinical outcomes in patients with atrial fibrillation and a history of falls using non-vitamin K antagonist oral anticoagulants : a nationwide cohort study
-
- Journal Article
- A1
- open access
Comparing the risk of dementia in subjects with atrial fibrillation using non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists : a Belgian nationwide cohort study
-
- Journal Article
- A1
- open access
Trends in oral anticoagulant use in patients with atrial fibrillation in Belgium from 2013 to 2019 : a nationwide cohort study
-
- Journal Article
- A1
- open access
Barriers and facilitators for adherence to direct oral anticoagulants in patients with atrial fibrillation : a qualitative approach
-
Impact of P-glycoprotein and CYP3A4-interacting drugs on clinical outcomes in patients with atrial fibrillation using non-vitamin K antagonist oral anticoagulants : a nationwide cohort study
-
Risico-batenprofiel van een standaard en een lagere dosis directe orale anticoagulantia versus warfarine bij patiënten met voorkamerfibrillatie
-
- Journal Article
- A1
- open access
Non-vitamin K antagonist oral anticoagulants (NOACs) versus warfarin in patients with atrial fibrillation and (morbid) obesity or low body weight : a systematic review and meta-analysis
-
Worldwide trends in oral anticoagulant use in patients with atrial fibrillation from 2010 to 2018 : a systematic review and meta-analysis